Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Fintel reports that on January 6, 2025, B of A Securities upgraded their outlook for Henry Schein (NasdaqGS:HSIC) from ...

Bank of America upgraded shares of Henry Schein (NASDAQ:HSIC – Free Report) from an underperform rating to a buy rating in a research report sent to investors on Monday, MarketBeat.com reports. Bank ...

As previously reported, BofA analyst Allen Lutz upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69, ...

Henry Schein has strategically set up distribution centers worldwide to better serve customers and increase its operating ...

Henry Schein Inc. closed $14.08 below its 52-week high ($82.63), which the company achieved on February 27th.

Valued at a market cap of $8.8 billion, Henry Schein, Inc. (HSIC) provides healthcare products and services to dental ...

Henry Schein is a candidate surfaced by a screen in this sector. It has many characteristics that I like in companies: easy-to-understand business, and profitable, among many others. There are ...

The leading distributor of healthcare products and services has a market capitalization of $9.12 billion. Henry Schein surpassed estimates in three of the trailing four quarters and missed the same in ...

Henry Schein is a leading global distributor of health-care products and services primarily to office-based dental and medical practitioners. The company operates through two segments that offer ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that ...

BofA upgraded Henry Schein (HSIC) to Buy from Underperform with an $84 price target Don't Miss Our New Year's Offers:Discover the latest stocks ...